<i>TP53</i> Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
Background: Identification of prognostic biomarkers in cancers is a crucial step to improve overall survival (OS). Although mutations in <i>tumour protein 53</i> (<i>TP53</i>) is prevalent in astrocytoma, the prognostic effects of <i>TP53</i> mutation are unclear....
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/45f3e58e52dd470a99b0524811570245 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!